SPONSOR
Case Comprehensive Cancer Center
Total Trials
10
Recruiting
10
Phases
Phase 2, Phase 1, Phase 2, Phase 1
Conditions studied: GlioblastomaBrain TumorTumors Metastatic to BrainHigh Grade GliomaEducational InterventionMinoritiesGraft Vs Host DiseaseVulvovaginal Signs and SymptomsAcute LeukemiaAcute Lymphoblastic Leukemia, Pediatric
Case Comprehensive Cancer Center is a clinical research sponsor with 10 registered studies on ClinicalTrials.gov, of which 10 are actively recruiting participants. Research covers conditions including Glioblastoma, Brain Tumor, Tumors Metastatic to Brain, High Grade Glioma.
The trial portfolio spans Phase 2, Phase 1, Phase 2, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Case Comprehensive Cancer Center
How many clinical trials has Case Comprehensive Cancer Center sponsored?
ClinicalMetric currently tracks 10 clinical trials sponsored by Case Comprehensive Cancer Center, of which 10 are actively recruiting participants. These trials cover conditions including Glioblastoma, Brain Tumor, Tumors Metastatic to Brain. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Case Comprehensive Cancer Center research focus on?
Case Comprehensive Cancer Center clinical trials span Glioblastoma, Brain Tumor, Tumors Metastatic to Brain, High Grade Glioma, Educational Intervention, and additional conditions. The research pipeline includes Phase 2, Phase 1, Phase 2, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Case Comprehensive Cancer Center clinical trial?
To participate in a Case Comprehensive Cancer Center trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Case Comprehensive Cancer Center trials with current recruitment status updated daily.
Clinical Trials by Case Comprehensive Cancer Center
NCT07003542 Phase 2
Recruiting
A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas
Glioblastoma
NCT01891318 Phase 1, Phase 2
Recruiting
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
Tumors Metastatic to Brain
NCT05565118 Phase 1
Recruiting
Prospective Surgical Study on the Pattern of Electrical Activity in High Grade Glioma as a Predictor of Progression
High Grade Glioma
NCT05701085
Recruiting
Patient Navigator PRE-ACT Educational Intervention to Promote Decision Making Among Minorities
Educational Intervention
NCT06649201
Recruiting
Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome Evaluation
Graft Vs Host Disease
NCT06421155
Recruiting
Brain MRF in Children, Adolescents and Young Adults With Acute Leukemia
Acute Leukemia
NCT06738303 Phase 2
Recruiting
Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer
Metastatic Prostate Cancer
NCT06687603
Recruiting
Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms
Barrett Esophagus
NCT06357845
Recruiting
Linking Somatic Mutation Rate With Baseline Exposure in East Palestine
Somatic Mutation
NCT07419581
Recruiting
A Study of Freeze-Dried Miracle Fruit (MiraBurst) on Participants Receiving Cancer Treatment
Dysgeusia
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology